PUBLIC

NEWS

Strategic Alliance with MedySapiens for Rare Disease Programs

2022-01-20

▲Moon Hong-sung, CEO of GENIXCURE (left), Kang Sang-gu, CEO of Medysapiens (right)

Prev
GXC101 funded 1M by a government R&D program by Ministry of Health and Welfare
Next
Signed Joint R&D Agreement with ToolGen
List